Related Experiment Video
Updated: Jul 19, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Stem cells for the treatment of diabetes
1Diabetes Research Institute Japan, Toyoake, Aichi.
Abstract:
Diabetes mellitus is a devastating disease and over 6% of the population is affected worldwide. The success achieved over the last few years with islet transplantation suggest that diabetes can be cured by the replenishment of deficient beta cells. These observations are proof of concept and have intensified interest in treating diabetes or other diseases not only by cell transplantation but also by stem cells. Work with ES cells has not yet produced cells with the phenotype of true beta cells, but there has been recent progress in directing ES cells to the endoderm. Bone marrow-derived stem cells could initiate pancreatic regeneration. Pancreatic stem/progenitor cells have been identified, and the formation of new beta cells from duct, acinar and liver cells is an active area of investigation. Some agents including glucagon-like peptide-1/exendin-4 can stimulate the regeneration of beta cells in vivo. Overexpression of embryonic transcription factors in stem cells could efficiently induce their differentiation into insulin-expressing cells. New technology, known as protein transduction technology, facilitates the differentiation of stem cells into insulin-producing cells. Recent progress in the search for new sources of beta cells has opened up several possibilities for the development of new treatments for diabetes.
Insights
Diabetes mellitus, affecting over 6% globally, shows promise for cures through beta cell replenishment. Research explores stem cells and regenerative medicine for new diabetes treatments.
Area of Science:
- Endocrinology
- Regenerative Medicine
- Stem Cell Biology
Background:
- Diabetes mellitus is a widespread, debilitating disease impacting over 6% of the global population.
- Islet transplantation offers a proof-of-concept for curing diabetes by replacing deficient beta cells.
- This success has spurred interest in cell and stem cell therapies for diabetes and other conditions.
Purpose of the Study:
- To review recent advancements in identifying and generating beta cells for potential diabetes treatment.
- To explore various stem cell sources and differentiation strategies for beta cell regeneration.
- To discuss novel technologies and therapeutic agents influencing beta cell regeneration.
Main Methods:
- Review of current literature on stem cell differentiation towards beta cells.
- Investigation of pancreatic stem/progenitor cell identification and potential.
- Analysis of factors and technologies promoting beta cell regeneration in vivo and in vitro.
Main Results:
- Embryonic stem (ES) cells show progress in differentiation towards endoderm, though not yet true beta cells.
- Bone marrow-derived stem cells and pancreatic stem/progenitor cells are investigated for regenerative capacity.
- Agents like glucagon-like peptide-1/exendin-4 and embryonic transcription factors show potential for stimulating beta cell regeneration.
- Protein transduction technology facilitates stem cell differentiation into insulin-producing cells.
Conclusions:
- Significant progress has been made in identifying new sources and methods for generating beta cells.
- Stem cell research, regenerative approaches, and novel technologies offer promising avenues for future diabetes treatments.
- The development of new beta cell sources holds potential for revolutionary diabetes therapies.
Related Concept Videos
iPS Cell Differentiation
Stem Cell Culture
Tissue Renewal without Stem Cells
However, failure of such a system...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

